<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04998695</url>
  </required_header>
  <id_info>
    <org_study_id>20193239</org_study_id>
    <nct_id>NCT04998695</nct_id>
  </id_info>
  <brief_title>Health Effects of Consuming Olive Pomace Oil</brief_title>
  <acronym>ORUJOSALUD-2</acronym>
  <official_title>Differential Study of the Health Effects of Olive Pomace Oil in Healthy and at Risk Consumers in Comparison With Sunflower Oil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Ciencia y Tecnología de Alimentos y Nutrición</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Ciencia y Tecnología de Alimentos y Nutrición</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Healthy and at risk (hypercholesterolemic) subjects consumed during 4 weeks 45 g/d of either&#xD;
      olive pomace oil (OPO) or sunflower oil (SO) as the only dietary fat in a randomized,&#xD;
      crossover trial. The effects on blood lipids, glucose homeostasis, endothelial function,&#xD;
      inflammatory cytokines, oxidative stress biomarkers and anthropometry were measured.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The intervention aimed at studying the potential health effects of olive pomace oil in&#xD;
      comparison with sunflower oil.&#xD;
&#xD;
      After a 3-weeks run-in, 31 healthy (normocholesterolemic) and 37 hypercholesterolemic&#xD;
      subjects were randomized to consume either OPO or SO (45 g/d) during 4 weeks, followed by a&#xD;
      3-week wash-out during which volunteers consumed the same amount of corn oil. During all the&#xD;
      study, other dietary sources of fat (oil, nuts, butter, etc.) were restricted. Food intake&#xD;
      was monitored by 3-d food records in each intervention stage and volunteers were instructed&#xD;
      to maintain their normal physical and dietary habits (except for the changes in the&#xD;
      consumption of other oils and fats).&#xD;
&#xD;
      At the beginning and end of each intervention stage, blood and urine samples were obtained,&#xD;
      and blood pressure and anthropometric measurements were performed. A complete batch of&#xD;
      analysis were performed, including serum lipids, endothelial function (endothelial nitric&#xD;
      oxide synthase (eNOS), vascular (VCAM-1) and intercellular (ICAM-1) cell adhesion molecules,&#xD;
      E- and P-selectins), inflammatory and anti-inflammatory cytokines, glucose&#xD;
      homeostasis/insulin resistance, antioxidant status and biomarkers of lipid oxidation&#xD;
      (malondialdehyde (MDA), LDLox, ferric reducing antioxidant power (FRAP), oxygen radical&#xD;
      absorbance capacity (ORAC), ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)&#xD;
      quenching capacity) and anthropometry, along with determination of incretins, adipokines, and&#xD;
      other clinical and hematological parameters.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 9, 2019</start_date>
  <completion_date type="Actual">December 20, 2019</completion_date>
  <primary_completion_date type="Actual">December 20, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>After a 3-week run-in, healthy and at risk (hypercholesterolemic) volunteers were randomly allocated to one of each arm.&#xD;
Each intervention stage lasted 4 weeks and was separated by a 3-week wash-out.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Oils were provided in unlabelled bottles (only differed in the colors of stoppers)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Blood lipids</measure>
    <time_frame>4 weeks</time_frame>
    <description>Reduction of total or LDL-cholesterol levels or triglycerides in at risk (hypercholesterolemic) subjects. No effect on blood lipids expected in healthy (normocholesterolemic) volunteers</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>4 weeks</time_frame>
    <description>Modification in the levels of selectins, adhesion molecules, or eNOS levels in volunteers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>4 weeks</time_frame>
    <description>Changes in systolic/diastolic blood pressure in volunteers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose homeostasis</measure>
    <time_frame>4 weeks</time_frame>
    <description>Modification of fasting blood glucose or insulin levels, decrease in glycosylated hemoglobin (Hb1Ac), homeostasis model assessment (HOMA) of insulin resistance (HOMA-IR) or beta-cell function (HOMA-beta)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation</measure>
    <time_frame>4 weeks</time_frame>
    <description>Concentration of serum pro-inflammatory cytokines/C-Reactive protein (CRP) modified in participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative status</measure>
    <time_frame>4 weeks</time_frame>
    <description>Modification of serum antioxidant capacity (FRAP, ABTS, ORAC, expressed as nM Trolox equivalents)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipid oxidation markers</measure>
    <time_frame>4 weeks</time_frame>
    <description>Concentration of biomarkers of lipid oxidation (MDA and/or LDLox) in serum modified</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Healthy</condition>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>Olive pomace oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intake of 45 g/d of olive pomace oil as the only source of oil in the diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sunflower oil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intake of 45 g/d of sunflower oil as the only source of oil in the diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Olive pomace oil</intervention_name>
    <description>Volunteers consumed during 4 weeks 45 g/d of olive pomace oil as the only source of dietary fat, used for cooking, salad dressing, toasts, etc.</description>
    <arm_group_label>Olive pomace oil</arm_group_label>
    <other_name>OPO</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sunflower oil</intervention_name>
    <description>Volunteers consumed during 4 weeks 45 g/d of sunflower oil as the only source of dietary fat, used for cooking, salad dressing, toasts, etc.</description>
    <arm_group_label>Sunflower oil</arm_group_label>
    <other_name>SO</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy volunteers (Total cholesterol &lt; 200 mg/dL; LDL-cholesterol &lt; 135 mg/dL)&#xD;
&#xD;
          -  Hypercholesterolemic volunteers (Total cholesterol 200-300 mg/dL; LDL-cholesterol&#xD;
             135-175 mg/dL)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  BMI &gt; 30 Kg/m2&#xD;
&#xD;
          -  Smokers&#xD;
&#xD;
          -  Vegetarians&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Medication/consumption of vitamins, dietary supplements&#xD;
&#xD;
          -  On antibiotic treatment 3 months before starting the study&#xD;
&#xD;
          -  Digestive disorders/pathologies (gastric ulcer, Chron's disease, inflammatory bowel&#xD;
             syndrome, etc.)&#xD;
&#xD;
          -  Food allergies/intolerances&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raquel Mateos, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>ICTAN-CSIC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto de Ciencia y Tecnología de Alimentos y Nutrición</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 4, 2021</study_first_submitted>
  <study_first_submitted_qc>August 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2021</study_first_posted>
  <last_update_submitted>August 9, 2021</last_update_submitted>
  <last_update_submitted_qc>August 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto de Ciencia y Tecnología de Alimentos y Nutrición</investigator_affiliation>
    <investigator_full_name>Laura Bravo</investigator_full_name>
    <investigator_title>Profesor</investigator_title>
  </responsible_party>
  <keyword>Olive pomace oil</keyword>
  <keyword>Lipaemia</keyword>
  <keyword>Glucose homeostasis</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Oxidative stress biomarkers</keyword>
  <keyword>Endothelial function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

